Anagnostics, Austrian Blood Bank Developing New Target Enrichment Method
April 19, 2011
Anagnostics, Austrian Blood Bank Developing New Target Enrichment Method
The blood bank will use the new enrichment approach, developed on Anagnostics' three-dimensional Hybcell array platform, for applications such as human leukocyte antigen subtyping.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Anagnostics Obtains CE-IVD Mark for Sepsis Test, Adds Belgian Distributor
October 16, 2012 / BioArray News - Anagnostics Partners with Molzym to Develop Sepsis Chip, Adds Austrian Distributor
July 10, 2012 / BioArray News - Anagnostics Taps Ramcon to Sell HybCell Array Platform in Nordic Region
February 7, 2012 / BioArray News - Anagnostics Partners with Vela Labs to Reach Pharma, Biotech Customers
August 30, 2011 / BioArray News - Anagnostics to Introduce Compact Gene Sequencing on Cylindrical HybCell Array Platform
October 26, 2010 / BioArray News